CYP-Mediated Therapeutic Protein-Drug Interactions: Clinical Findings, Proposed Mechanisms and Regulatory Implications

By Lee Jang-Ik  

Clinical Pharmacokinetics, Vol. 49, Iss. 5, 2010-05 ,pp. : 295-310

Adis International

Access to resources Recommend Favorite

Phosphorylation and protein–protein interactions in PXR-mediated CYP3A repression

By Pondugula Satyanarayana R   Dong Hanqing   Chen Taosheng  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 861-873

Informa Healthcare

Access to resources Recommend Favorite

CYP3A4-mediated Pharmacokinetic Interactions in Cancer Therapy

By  

Current Drug Metabolism, Vol. 15, Iss. 8, 2014-10 ,pp. : 808-817

Bentham Science Publishers

Access to resources Recommend Favorite

Quantitative Prediction of Cytochrome P450 (CYP) 2D6-Mediated Drug Interactions

By Tod Michel   Goutelle Sylvain   Clavel-Grabit Fannie   Nicolas Grégoire   Charpiat Bruno  

Clinical Pharmacokinetics, Vol. 50, Iss. 8, 2011-08 ,pp. : 519-530

Adis International

Access to resources Recommend Favorite

In Vivo Animal Models for Investigating Potential CYP3A- and Pgp-Mediated Drug-Drug Interactions

By  

Current Drug Metabolism, Vol. 7, Iss. 7, 2006-10 ,pp. : 687-704

Bentham Science Publishers

Access to resources Recommend Favorite